Clinical Trial Update: Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine [Phase 1, Phase 2]

View source ↗

Summary

This trial update covers a Phase 1/Phase 2 study of laromustine combined with infusional cytarabine in elderly patients with acute myeloid leukemia or high-risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Cytarabine (infusional) (cytarabine)
• Laromustine (laromustine)

Snippet

Sponsor: Viron Therapeutics Inc | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 1, Phase 2 | Status: TERMINATED